Increased research
and development efforts have greatly contributed to the growth of the
immunoprotein diagnostic testing market in recent years, states a
recent report published by Transparency Market Research. The report,
titled “Immunoprotein Diagnostic Testing Market - Global Industry
Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”,
indicates that, registering a CAGR of 5.7% from 2013 and 2019, the
global immunoprotein diagnostic testing market stands to expand from
US$11,019.7 million in 2012 to US$15,351.0 million in 2019.
The research report
segments the global immunoprotein diagnostic testing market on the
basis of assay technology, immunoprotein type, application, and
geography. By the type of immunoprotein tested, the market is
categorized into C-reactive protein diagnostic tests, free light
chain diagnostic tests, prealbumin diagnostic tests, complement
system protein diagnostic tests, immunoglobulin diagnostic tests, and
haptoglobin diagnostic tests. The C-reactive protein diagnostic test
has been the largest segment owing to its effective and accurate
diagnosis of injuries, inflammation-related disorders, strokes, and
cardiovascular diseases. However, analysts believe that, being in the
initial stages of development, the segment of free light chain
diagnostic tests is likely to pick up pace in the near future.
Browse the full
Immunoprotein Diagnostic Testing Market Report @ :http://www.transparencymarketresearch.com/immunoprotein-diagnostic-testing.html
On the basis of
technology, the market for immunoprotein diagnostic testing is
segmented into enzyme-based immunoassay, radioimmunoassay,
chemiluminescence assay, immunofluorescence assay, immunoprotein
electrophoresis, and immunoturbidity assay. The chemiluminecence
assay segment dominated the global immunoprotein diagnostic testing
market in 2012, due to its feasibility for wide-scale application,
sensitivity, safety, and ease of use. The segment of radioimmunoassay
testing has been losing market share over the years owing to high
cost of equipment and devices, strict healthcare regulations, and
high exposure to radiation. Doctors and clinicians have switched to
safer and more effective tests, leading to a decline in the
radioimmunoassay testing market.
Browse the full
Immunoprotein Diagnostic Testing Market Press Release @ :http://www.transparencymarketresearch.com/pressrelease/immunoprotein-diagnostic-testing.htm
Immunoprotein
diagnostic testing finds application in endocrine testing, allergy
testing, infectious diseases, toxicology testing, oncology testing,
and autoimmune disease testing. The report indicates that the segment
of oncology testing will generate maximum revenue by the end of the
forecast period, presenting a market worth of US$4,943.0 million in
2019 and growing at a CAGR of 6% from 2013 to 2019.The report
identifies some of the major factors governing the growth of the
immunoprotein diagnostic testing market. According to the report, the
growing demand for quick, accurate, and preventive healthcare –
especially in emerging economies – is a primary factor boosting the
global market. In addition, technological development,
commoditization of products, expansion in the field of
immunochromatography, and strengthening network of distributors at a
global level has also contributed to the growth of the immunoprotein
diagnostic testing market. In contrast, high cost of diagnosis is
likely to restrict the development of this market over the forecast
period.
Some of the leading
players in the global immunoprotein diagnostic testing market are
DiaSorin SPA, Thermo Fisher Scientific, Inc., The Binding Site Group
Ltd., Abcam PLC, Omega Diagnostics Group PLC, Randox Laboratories
Ltd., Siemens AG, Enzo Life Sciences, Inc., Roche Holding AG,
Fujirebio Diagnostics, Inc., and Abbott Laboratories, Inc. These
players are profiled on the basis of parameters such as company and
financial overview, recent developments, product portfolio, business
strategies, and a SWOT analysis.
Get Free Sample
Report :http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=1253
About Us :
Transparency Market
Research (TMR) is a global market intelligence company providing
business information reports and services. The company’s exclusive
blend of quantitative forecasting and trend analysis provides
forward-looking insight for thousands of decision makers. TMR’s
experienced team of analysts, researchers, and consultants use
proprietary data sources and various tools and techniques to gather
and analyze information.
TMR’s data
repository is continuously updated and revised by a team of research
experts so that it always reflects the latest trends and information.
With extensive research and analysis capabilities, Transparency
Market Research employs rigorous primary and secondary research
techniques to develop distinctive data sets and research material for
business reports.
No comments:
Post a Comment